课题基金 / 基金详情

Dissecting SUMO Activating Enzyme Pathways to Inform Therapy

Dissecting SUMO Activating Enzyme Pathways to Inform Therapy
剖析 SUMO 激活酶途径以指导治疗
批准号:
MR/X001008/1
负责人:
Joanna Morris
金额:
$93.14万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

Joanna Morris的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One cell becomes two by dividing its DNA, in packets of chromosomes, into two daughter cells. This process is supported by a tiny protein that is added to other proteins to help the packets divide correctly. Correct DNA division is particularly important in some cancers that are driven by a particular genetic change, called Myc amplification. New drugs that stop the small protein from being added appear to be useful in killing cancers that have this genetic change. We have recently discovered that the target of those drugs behaves in surprising ways. Instead of having a single role as previously thought, we find it has at least two different functions; one of these is in the poorly understood process of helping DNA remain undamaged as it is divided into the daughter cells. Our aims in this project are to investigate how the drug target behaves in these different ways, to find out which one of them is most important in supporting cancer cell survival, and to discover how it works to prevent DNA damage. This work has implications for how the new drugs are used to help cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RecombInsight: Discovery in Mammalian Homologous Recombination DNA Repair
  • 批准号:
    EP/X023087/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $240.06万
  • 财政年份:
    2023
  • 负责人:
    Joanna Morris
  • 依托单位:
国内基金
海外基金
ALKBH5 SUMO化-YTHDF2介导FBXW7 m6A修饰在宫腔粘连诱发子宫内膜细胞端粒损伤和细胞衰老的机制研究
  • 批准号:
    2026JJ50624
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    冯晴
  • 依托单位:
线粒体膜钙离子转运蛋白MCU的SUMO化修饰介导apelin-13促单核细胞-血管内皮细胞粘附影响
PIAS1通过增加KDM6A SUMO化修饰表观下调CAV1抑制铁死亡在急性肺损伤中的机制研究
  • 批准号:
    2026JJ80669
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    陈阳晔
  • 依托单位:
OGT介导O-GlcNAc糖基化修饰SENP1调控EGFR去SUMO化促进结直肠癌对西妥昔单抗治疗耐药的机制研究
  • 批准号:
    2026JJ81361
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周园
  • 依托单位: